S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:ABUS

Arbutus Biopharma News Headlines

$3.30
+0.16 (+5.10 %)
(As of 03/5/2021 07:37 PM ET)
Add
Compare
Today's Range
$2.91
Now: $3.30
$3.30
50-Day Range
$3.14
MA: $4.05
$4.84
52-Week Range
$0.88
Now: $3.30
$9.02
Volume3.75 million shs
Average Volume3.06 million shs
Market Capitalization$280.20 million
P/E RatioN/A
Dividend YieldN/A
Beta3.15

Headlines

Arbutus Biopharma (NASDAQ ABUS) News Headlines Today

Source:
SourceHeadline
Arbutus Biopharma (NASDAQ:ABUS) Now Covered by Jefferies Financial GroupArbutus Biopharma (NASDAQ:ABUS) Now Covered by Jefferies Financial Group
marketbeat.com - February 25 at 7:54 AM
Arbutus Biopharma (NASDAQ:ABUS) Trading 5.1% Higher Arbutus Biopharma (NASDAQ:ABUS) Trading 5.1% Higher
americanbankingnews.com - March 5 at 8:48 PM
Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly  Earnings Results, Misses Expectations By $0.01 EPSArbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
americanbankingnews.com - March 5 at 10:54 AM
Arbutus Biopharma (NASDAQ:ABUS)  Shares Down 13.7% Arbutus Biopharma (NASDAQ:ABUS) Shares Down 13.7%
americanbankingnews.com - March 4 at 9:35 PM
Recap: Arbutus Biopharma Q4 EarningsRecap: Arbutus Biopharma Q4 Earnings
benzinga.com - March 4 at 9:07 AM
Arbutus Biopharma Corp. to Host Earnings CallArbutus Biopharma Corp. to Host Earnings Call
finance.yahoo.com - March 4 at 9:07 AM
Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate UpdateArbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 4 at 9:07 AM
Earnings Preview: Arbutus BiopharmaEarnings Preview: Arbutus Biopharma
finance.yahoo.com - March 3 at 5:59 PM
Is a Surprise Coming for Arbutus Biopharma (ABUS) This Earnings Season?Is a Surprise Coming for Arbutus Biopharma (ABUS) This Earnings Season?
finance.yahoo.com - March 3 at 12:58 PM
Zacks: Analysts Expect Arbutus Biopharma Co. (NASDAQ:ABUS) to Announce -$0.23 EPSZacks: Analysts Expect Arbutus Biopharma Co. (NASDAQ:ABUS) to Announce -$0.23 EPS
americanbankingnews.com - March 2 at 10:14 PM
Arbutus to Participate at H.C. Wainwright Global Life Sciences ConferenceArbutus to Participate at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:55 AM
Arbutus Biopharma (NASDAQ:ABUS) Coverage Initiated at Jefferies Financial GroupArbutus Biopharma (NASDAQ:ABUS) Coverage Initiated at Jefferies Financial Group
americanbankingnews.com - February 25 at 9:02 AM
Arbutus Biopharma (ABUS) to Release Earnings on ThursdayArbutus Biopharma (ABUS) to Release Earnings on Thursday
americanbankingnews.com - February 25 at 2:10 AM
Arbutus Biopharma (NASDAQ:ABUS) Trading 15.4% Higher Arbutus Biopharma (NASDAQ:ABUS) Trading 15.4% Higher
americanbankingnews.com - February 24 at 7:20 PM
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 10.7%Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 10.7%
americanbankingnews.com - February 23 at 8:32 PM
Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate UpdateArbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - February 22 at 9:00 AM
Arbutus Biopharma Co. (NASDAQ:ABUS) Receives Consensus Rating of "Buy" from AnalystsArbutus Biopharma Co. (NASDAQ:ABUS) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - February 19 at 9:10 AM
Heres What Arbutus Biopharma Corporations (NASDAQ:ABUS) Shareholder Ownership Structure Looks LikeHere's What Arbutus Biopharma Corporation's (NASDAQ:ABUS) Shareholder Ownership Structure Looks Like
finance.yahoo.com - February 15 at 9:40 AM
ABUS Feb 2021 5.000 callABUS Feb 2021 5.000 call
uk.finance.yahoo.com - January 26 at 7:18 PM
Arbutus: A Promising Pure-Play On The $2.13 Billion Global Hepatitis B MarketArbutus: A Promising Pure-Play On The $2.13 Billion Global Hepatitis B Market
seekingalpha.com - January 26 at 7:18 PM
Arbutus Announces 2021 Corporate Objectives and Provides Financial UpdateArbutus Announces 2021 Corporate Objectives and Provides Financial Update
finance.yahoo.com - January 25 at 8:42 AM
ABUS Feb 2021 7.500 callABUS Feb 2021 7.500 call
uk.finance.yahoo.com - January 23 at 7:01 PM
ABUS Jan 2021 10.000 putABUS Jan 2021 10.000 put
uk.finance.yahoo.com - January 13 at 11:02 PM
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 ConferenceArbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference
finance.yahoo.com - January 4 at 8:30 AM
Are Investors Undervaluing Arbutus Biopharma Corporation (NASDAQ:ABUS) By 26%?Are Investors Undervaluing Arbutus Biopharma Corporation (NASDAQ:ABUS) By 26%?
finance.yahoo.com - January 1 at 8:24 AM
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional MethodsWhy Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
marketwatch.com - December 15 at 12:35 PM
Is ABUS A Good Stock To Buy Now?Is ABUS A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 6:59 PM
Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?
marketwatch.com - December 10 at 2:30 PM
Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B SubjectsArbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects
finance.yahoo.com - December 10 at 2:30 PM
ABUS Dec 2020 10.000 putABUS Dec 2020 10.000 put
au.finance.yahoo.com - November 29 at 4:15 PM
Arbutus AB-729 shows encouraging results in chronic hepatitis BArbutus' AB-729 shows encouraging results in chronic hepatitis B
seekingalpha.com - November 16 at 10:01 AM
Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B SubjectsArbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects
finance.yahoo.com - November 16 at 10:01 AM
Implied Volatility Surging for Arbutus Biopharma (ABUS) Stock OptionsImplied Volatility Surging for Arbutus Biopharma (ABUS) Stock Options
finance.yahoo.com - November 12 at 1:49 PM
Arbutus to Present at Jefferies Virtual London Healthcare ConferenceArbutus to Present at Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 9:00 AM
Earnings Update: Arbutus Biopharma Corporation (NASDAQ:ABUS) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: Arbutus Biopharma Corporation (NASDAQ:ABUS) Just Reported And Analysts Are Trimming Their Forecasts
nasdaq.com - November 7 at 12:18 PM
Arbutus Biopharma Corporation (NASDAQ:ABUS) Analysts Are Cutting Their Estimates: Heres What You Need To KnowArbutus Biopharma Corporation (NASDAQ:ABUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 7:17 AM
Arbutus Biopharma Corporation (ABUS) CEO Bill Collier on Q3 2020 Results - Earnings Call TranscriptArbutus Biopharma Corporation (ABUS) CEO Bill Collier on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 5:29 PM
Arbutus Biopharma EPS misses by $0.05, misses on revenueArbutus Biopharma EPS misses by $0.05, misses on revenue
seekingalpha.com - November 5 at 12:29 PM
Return On Capital Employed Overview: Arbutus BiopharmaReturn On Capital Employed Overview: Arbutus Biopharma
benzinga.com - November 4 at 11:26 AM
We're Keeping An Eye On Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn RateWe're Keeping An Eye On Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate
finance.yahoo.com - October 16 at 2:13 PM
Arbutus to Participate in Virtual Fireside Chat at Chardans 4th Annual Genetic Medicines ConferenceArbutus to Participate in Virtual Fireside Chat at Chardan's 4th Annual Genetic Medicines Conference
marketwatch.com - September 28 at 11:27 PM
Thinking about buying stock in Arbutus Biopharma, TRACON Pharmaceuticals, Workhorse Group, Trevena, or Cassava Sciences?Thinking about buying stock in Arbutus Biopharma, TRACON Pharmaceuticals, Workhorse Group, Trevena, or Cassava Sciences?
marketwatch.com - September 17 at 5:43 PM
Why Arbutus Stock Is Trading Higher TodayWhy Arbutus Stock Is Trading Higher Today
msn.com - September 15 at 12:25 PM
Arbutus AB-729 shows positive action in HBV studyArbutus' AB-729 shows positive action in HBV study
seekingalpha.com - September 15 at 12:25 PM
Bucks County firms stock surges on positive study data for hepatitis B therapyBucks County firm's stock surges on positive study data for hepatitis B therapy
bizjournals.com - September 15 at 12:25 PM
Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAgArbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAg
finance.yahoo.com - September 15 at 12:25 PM
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright 22nd Annual Global Investment ConferenceArbutus to Participate in Virtual Fireside Chat at H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 9 at 9:15 AM
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA ApprovalAs CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval
msn.com - September 4 at 6:15 PM
Ebola Treatment Market Analysis and Global Research Report 2020 to 2026Ebola Treatment Market Analysis and Global Research Report 2020 to 2026
marketwatch.com - August 28 at 4:59 AM
Assembly Biosciences teams up with Arbutus Biopharma in chronic HBV infectionAssembly Biosciences teams up with Arbutus Biopharma in chronic HBV infection
seekingalpha.com - August 27 at 8:49 AM
Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepatitis B Virus InfectionAssembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepatitis B Virus Infection
finance.yahoo.com - August 27 at 8:49 AM
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.